涙管デバイス市場の市場規模、シェア、成長分析：製品別、用途別、最終用途別、地域別 - 産業予測 2025～2032年

涙管デバイス市場規模は、2023年に1億6,519万米ドルと評価され、2024年の1億7,147万米ドルから2032年には2億3,108万米ドルに成長し、予測期間（2025-2032年）のCAGRは3.8%で成長する見通しです。

涙管デバイス市場は、あらゆる年齢層で眼科疾患に対する認識と診断が高まっていることが牽引して力強い成長を遂げています。眼に関連する疾患の増加に伴い、穿刺栓、涙点ステント、灌流システムなどの高度なデバイスに対する需要が増加しています。技術の進歩と手術手技の向上が患者の予後を改善し、市場の拡大をさらに後押ししています。人口の高齢化は、加齢に関連する眼疾患の急増と相まって、この成長軌道を支えています。メーカーやヘルスケアプロバイダーは、ケアの質と快適性を重視し、涙腺障害患者のニーズに対応したソリューションを革新しています。規制要因や償還政策も市場力学に大きな影響を与えています。全体として、この市場は、患者中心のソリューションと治療結果の向上に重点を置く眼科機器メーカーに有利な機会を提供しています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• ケーススタディ
• 規制情勢
• 特許分析

涙管デバイス市場規模：製品別& CAGR（2025-2032）

• 市場概要
• 挿管セット
• ステントとチューブ
• カニューレとスパチュラ
• 拡張器

涙管デバイス市場規模：用途別& CAGR（2025-2032）

• 市場概要
• 緑内障
• ドライアイ
• 涙腺炎
• 流涙症
• その他

涙管デバイス市場規模：最終用途別& CAGR（2025-2032）

• 市場概要
• 病院
• 診断センター
• 外来ケアセンター（ACC）

涙管デバイス市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• FCI Ophthalmics（France）
• Kaneka Corporation（Japan）
• Cook Group（USA）
• BVI（UK）
• Rumex International（USA）
• Bess Medical Technology GmbH（Germany）
• Bausch and Lomb Incorporated（USA）
• Braun Melsungen AG（Germany）
• OASIS Medical, Inc.（USA）
• Beaver-Visitec International（USA）
• FC Optics Ltd.（Israel）
• OptiMedica Corporation（USA）
• Diamatrix Ltd.（UK）
• FCI S.A.S.（France）
• Novartis AG（Switzerland）
• Eye Kon Medical, Inc.（USA）

結論と提言

Lacrimal Devices Market size was valued at USD 165.19 million in 2023 and is poised to grow from USD 171.47 million in 2024 to USD 231.08 million by 2032, growing at a CAGR of 3.8% during the forecast period (2025-2032).

The lacrimal devices market is experiencing robust growth driven by heightened awareness and diagnosis of ophthalmic conditions across all age demographics. With a rise in eye-related disorders, there's an increased demand for advanced devices like punctal plugs, lacrimal stents, and irrigation systems. Technological advancements and improved surgical techniques have enhanced patient outcomes, propelling market expansion further. The aging population, coupled with a surge in age-related ocular issues, sustains this growth trajectory. Manufacturers and healthcare providers are innovating solutions tailored to address the needs of patients with lacrimal disorders, emphasizing quality of care and comfort. Regulatory factors and reimbursement policies also significantly impact market dynamics. Overall, this market presents lucrative opportunities for ophthalmic device companies focused on patient-centric solutions and enhanced treatment results.

Top-down and bottom-up approaches were used to estimate and validate the size of the Lacrimal Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Lacrimal Devices Market Segments Analysis

Global Lacrimal Devices Market is segmented by Product, Application, End-use and region. Based on Product, the market is segmented into Intubation Sets, Stents and Tubes, Cannula and Spatula and Dilators. Based on Application, the market is segmented into Glaucoma, Dry Eye, Lacrimal Gland Inflammation, Epiphora and Others. Based on End-use, the market is segmented into Hospitals, Diagnostic Centers and Ambulatory Care Centers (ACC). Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Lacrimal Devices Market

The lacrimal devices market is primarily driven by the rising prevalence of eye disorders worldwide. Contributing factors include an aging population, evolving lifestyles, and increased screen time, all of which have led to a surge in conditions such as dry eye syndrome and other disorders affecting the lacrimal system. As a result, there is a heightened demand for lacrimal devices designed to facilitate the diagnosis and treatment of these issues, significantly stimulating market expansion. Furthermore, greater awareness and advances in technology are likely to enhance the adoption of these devices, further fueling growth in the lacrimal devices sector.

Restraints in the Lacrimal Devices Market

A significant constraint in the lacrimal devices market is the tough regulatory environment, along with the potential for delays in securing approvals for new products or modifications. In regions like North America and Europe, regulatory agencies impose rigorous standards for medical devices, which can extend the time required for market entry. These challenges not only hinder the pace of innovation but also affect market expansion, presenting difficulties for both established companies and new market entrants. Consequently, navigating this complicated approval process can stunt overall growth within the lacrimal devices sector, limiting opportunities for advancement and development.

Market Trends of the Lacrimal Devices Market

The lacrimal devices market is witnessing a pronounced shift towards minimally invasive procedures, reflecting a broader trend in healthcare that prioritizes patient comfort and quicker recovery. Both patients and healthcare professionals are increasingly favoring techniques that minimize surgical intervention for lacrimal system disorders, resulting in fewer postoperative complications. This growing demand for less invasive solutions has spurred innovation in the development of advanced lacrimal devices, including microendoscopes, specialized catheters, and other state-of-the-art tools. As these technologies evolve, they are set to enhance treatment efficacy and redefine patient care standards, positioning minimally invasive options as the preferred choice in the lacrimal devices market.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Patent Analysis

Global Lacrimal Devices Market Size by Product & CAGR (2025-2032)

• Market Overview
• Intubation Sets
• Stents and Tubes
• Cannula and Spatula
• Dilators

Global Lacrimal Devices Market Size by Application & CAGR (2025-2032)

• Market Overview
• Glaucoma
• Dry Eye
• Lacrimal Gland Inflammation
• Epiphora
• Others

Global Lacrimal Devices Market Size by End-use & CAGR (2025-2032)

• Market Overview
• Hospitals
• Diagnostic Centers
• Ambulatory Care Centers (ACC)

Global Lacrimal Devices Market Size & CAGR (2025-2032)

• North America (Product, Application, End-use)
  • US
  • Canada
• Europe (Product, Application, End-use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Application, End-use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Application, End-use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Application, End-use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• FCI Ophthalmics (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kaneka Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Group (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BVI (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rumex International (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bess Medical Technology GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bausch and Lomb Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OASIS Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beaver-Visitec International (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FC Optics Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OptiMedica Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Diamatrix Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FCI S.A.S. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novartis AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eye Kon Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations